// App-Quantinova.ai

6326 : Reshaping immune lung populations to inhibit pulmonary fibrosis and cancer by activation of purinergic receptor P2RX7

Researchers

Presenter

  • Serena Janho dit Hreich

Principal Investigators

  • Alina Ghinet

  • Valérie Vouret-Craviari

Medical Centers

  • IRCAN - Institute for Research on Cancer and Ageing of Nice, Nice, France

  • Junia, Lille, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

  • Non Small Cell Lung cancer

  • Small cell lung cancer

  • Pulmonary fibrosis

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Natural Killer cells

  • Interleukin 17A

  • Interleukin 18

  • T helper 2

Drug/Treatment

  • Bleomycin

  • IFN-lambda

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved